.: ORİJİNAL ARAŞTIRMA
Orta Karadeniz Bölgesi'nde Bir Üçüncü Basamak Tedavi Merkezinde Preterm İnfantlardaki Prematüre Retinopatisi İnsidansı
The Incidence of Retinopathy of Prematurity in the Preterm Infants in a Tertiary Center in the Middle Black Sea Region
Turkiye Klinikleri J Pediatr. 2019;28(3):115-20
doi: 10.5336/pediatr.2019-65654
Makale Dili: TR
Tam Metin
Ücretsiz Erişim
ÖZET
Amaç: Prematüre retinopatisi [retinopathy of prematurity (ROP)] tarama muayenesi yapılan preterm infantlarda ROP varlığı, muayene bulguları ve tedavi oranlarını incelemektir. Gereç ve Yöntemler: Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesinde, Ocak 2015-2017 tarihleri arasında ROP için takip edilmiş preterm infantların kayıtları retrospektif olarak incelendi. Doğum haftası (DH) ≤34 hafta veya doğum ağırlığı (DA)≤1.750 g olan bebekler çalışmaya dâhil edildi. Cinsiyet, DH, DA, kuvöz süresi, ROP varlığı ve derecesi ile ROP için tedavi gereksinimi kaydedilerek analiz edildi. Bulgular: Çalışmaya 395 (%51,2)'i kız 377 (%48,8)'si erkek olan toplam 772 infant dâhil edildi. Ortalama DH 30,2±2,2 hafta ve ortalama DA 1.314±302 g idi. Bebeklerin 413 (%53,5)'ünde herhangi bir evre ROP tespit edildi. Cinsiyetin ROP gelişimi ile ilişkisi yoktu (p=0,808). ROP gelişen bebeklerin DH ve DA sırası ile 29,5 hafta ve 1.219 g idi ve her iki değişken de ROP gelişimi ile ilişkiliydi (p<0,001). ROP gelişen ve gelişmeyen bebeklerin ortalama kuvözde kalma süreleri sırası ile 43 ve 27 gündü (p<0,001). Yetmiş üç (%9,5) bebeğe ROP tedavisi uygulanmıştı. Tedavi oranı erkek bebeklerde %11,4 iken, kız bebeklerde %7,6 idi (p=0,071). DH≥32 hafta olan hiçbir bebekte tedavi gerekli olmadı. Sonuç: Çalışmamızda elde edilen ROP insidansı ve tedavi gereksinimi ülkemizde daha önceden belirtilen oranlar ile benzerdi. Düşük DH ve DA, ROP gelişimi için önemli risk faktörleriydi. Kuvözde kalma süresi daha uzun olan bebeklerde ROP görülme oranı daha fazla idi.
Anahtar Kelimeler: Prematüre retinopatisi; doğum haftası; doğum kilosu; insidans
Amaç: Prematüre retinopatisi [retinopathy of prematurity (ROP)] tarama muayenesi yapılan preterm infantlarda ROP varlığı, muayene bulguları ve tedavi oranlarını incelemektir. Gereç ve Yöntemler: Ondokuz Mayıs Üniversitesi Tıp Fakültesi Hastanesinde, Ocak 2015-2017 tarihleri arasında ROP için takip edilmiş preterm infantların kayıtları retrospektif olarak incelendi. Doğum haftası (DH) ≤34 hafta veya doğum ağırlığı (DA)≤1.750 g olan bebekler çalışmaya dâhil edildi. Cinsiyet, DH, DA, kuvöz süresi, ROP varlığı ve derecesi ile ROP için tedavi gereksinimi kaydedilerek analiz edildi. Bulgular: Çalışmaya 395 (%51,2)'i kız 377 (%48,8)'si erkek olan toplam 772 infant dâhil edildi. Ortalama DH 30,2±2,2 hafta ve ortalama DA 1.314±302 g idi. Bebeklerin 413 (%53,5)'ünde herhangi bir evre ROP tespit edildi. Cinsiyetin ROP gelişimi ile ilişkisi yoktu (p=0,808). ROP gelişen bebeklerin DH ve DA sırası ile 29,5 hafta ve 1.219 g idi ve her iki değişken de ROP gelişimi ile ilişkiliydi (p<0,001). ROP gelişen ve gelişmeyen bebeklerin ortalama kuvözde kalma süreleri sırası ile 43 ve 27 gündü (p<0,001). Yetmiş üç (%9,5) bebeğe ROP tedavisi uygulanmıştı. Tedavi oranı erkek bebeklerde %11,4 iken, kız bebeklerde %7,6 idi (p=0,071). DH≥32 hafta olan hiçbir bebekte tedavi gerekli olmadı. Sonuç: Çalışmamızda elde edilen ROP insidansı ve tedavi gereksinimi ülkemizde daha önceden belirtilen oranlar ile benzerdi. Düşük DH ve DA, ROP gelişimi için önemli risk faktörleriydi. Kuvözde kalma süresi daha uzun olan bebeklerde ROP görülme oranı daha fazla idi.
Anahtar Kelimeler: Prematüre retinopatisi; doğum haftası; doğum kilosu; insidans
ABSTRACT
Objective: To evaluate the presence, findings and treatment rates of retinopathy of prematurity (ROP) in preterm infants screened for ROP. Material and Methods: The medical records of preterm infants who were screened for ROP at Ondokuz Mayıs University Hospital Ophthalmology Clinic between January 2015-2017 were retrospectively reviewed. Babies with a gestational age (GA) of ≤34 weeks or birth weight (BW) of ≤1.750 grams were included in the study. The gender, GA, BW, incubation time, the presence and severity of ROP, and treatment requirement for ROP were recorded and analyzed. Results: A total of 772 infants were included in the study: 395 (51.2%) were female and 377 (48.8%) were male. The mean GA was 30.2±2.2 weeks and the mean BW was 1.314±302 grams. Any stage ROP was detected in 413 (53.5%) infants. Gender was not associated with the development of ROP (p=0.808). The GA and BW of the infants with ROP were 29.5 weeks and 1.219 grams, and both variables were associated with the development of ROP (p<0.001). Babies with and without ROP stayed in the incubator for an average of 43 and 27 days, respectively (p<0.001). Seventy three (9.5%) infants were treated for ROP. The rate of treatment was 11.4% for male and 7.6% for female infants (p=0.071). No infants with DH≥32 weeks required treatment. Conclusion: The incidence of ROP and the need for treatment in our study were similar to those reported previously in our country. Low GA and BW were important risk factors for the development of ROP. The incidence of ROP was higher in infants who stayed longer in the incubator.
Keywords: Retinopathy of prematurity; gestational age; birth weight; incidence
Objective: To evaluate the presence, findings and treatment rates of retinopathy of prematurity (ROP) in preterm infants screened for ROP. Material and Methods: The medical records of preterm infants who were screened for ROP at Ondokuz Mayıs University Hospital Ophthalmology Clinic between January 2015-2017 were retrospectively reviewed. Babies with a gestational age (GA) of ≤34 weeks or birth weight (BW) of ≤1.750 grams were included in the study. The gender, GA, BW, incubation time, the presence and severity of ROP, and treatment requirement for ROP were recorded and analyzed. Results: A total of 772 infants were included in the study: 395 (51.2%) were female and 377 (48.8%) were male. The mean GA was 30.2±2.2 weeks and the mean BW was 1.314±302 grams. Any stage ROP was detected in 413 (53.5%) infants. Gender was not associated with the development of ROP (p=0.808). The GA and BW of the infants with ROP were 29.5 weeks and 1.219 grams, and both variables were associated with the development of ROP (p<0.001). Babies with and without ROP stayed in the incubator for an average of 43 and 27 days, respectively (p<0.001). Seventy three (9.5%) infants were treated for ROP. The rate of treatment was 11.4% for male and 7.6% for female infants (p=0.071). No infants with DH≥32 weeks required treatment. Conclusion: The incidence of ROP and the need for treatment in our study were similar to those reported previously in our country. Low GA and BW were important risk factors for the development of ROP. The incidence of ROP was higher in infants who stayed longer in the incubator.
Keywords: Retinopathy of prematurity; gestational age; birth weight; incidence
REFERANSLAR:
- Palmer EA. Retinopathy of prematurity. In: Schachat AP, eds. Retina Vol II. 4th ed. Philadelphia: Elsevier Mosby; 2006. p.1447-74. [Crossref]
- Bas AY, Koc E, Dilmen U. Incidence and severity of retinopathy of prematurity in Turkey. Br J Ophthalmol. 2015;99(10):1311-4. [Crossref] [PubMed]
- Kulacoglu DN, Sertoz AD, Ates O, Baykal O. [Risk factors in premature retinopathy and screening results]. Ret-Vit. 2005;13:33-7.
- Altunbas HH, Kir N, Ovali T, Dagoglu T. [Retinopathy of prematurity: clinical course and risk factors]. T Oft Gaz. 2002;32:286-90.
- Sarikabadayi YU, Aydemir O, Ozen ZT, Aydemir C, Tok L, Oguz SS, et al. Screening for retinopathy of prematurity in a large tertiary neonatal intensive care unit in Turkey: frequency and risk factors. Ophthalmic Epidemiol. 2011;18(6):269-74. [Crossref] [PubMed]
- WHO's mission for vision. Afr Health. 1998;20(5):38.
- Shah PK, Narendran V, Kalpana N, Gibert C. Severe retinopathy of prematurity in big babies in India: history repeating itself? Indian J Pediatr. 2009;76(8):801-4. [Crossref] [PubMed]
- Chen Y, Li X. Characteristics of severe retinopathy of prematurity patients in China: a repeat of the first epidemic? Br J Ophthalmol. 2006;90(3):268-71. [Crossref] [PubMed] [PMC]
- Kong L, Fry M, Al-Samarraie M, Gilbert C, Steinkuller PG. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS. 2012;16(6):501-7. [Crossref] [PubMed]
- Section on Ophthalmology American Academy of Pediatrics; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006;117(2):572-6. [Crossref]
- Multicenter trial of cryotherapy for retinopathy of prematurity. Three-month outcome. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1990;108(2):195-204. [Crossref] [PubMed]
- Early Treatment for Retinopathy of prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for Retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003;121(12):1684-96. [Crossref] [PubMed]
- Palmer EA, Flynn JT, Hardy RJ, Phelps DL, Phillips CL, Schaffer DB, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991;98(11):1628-40.
- Lee SK, McMillan DD, Ohlsson A, Pendray M, Synnes A, Whyte R, et al. Variations in practice and outcomes in the Canadian NICU network: 1996-1997. Pediatrics. 2000;106(5): 1070-9. [Crossref] [PubMed]
- Isaza G, Arora S, Bal M, Chaudhary V. Incidence of retinopathy of prematurity and risk factors among premature infants at a neonatal intensive care unit in Canada. J Pediatr Ophthalmol Strabismus. 2013;50(1):27-32. [Crossref] [PubMed]
- Ziylan S, Ulasan S, Camurlu SE, Ozkozaci T, Karatekin G. [Risk factors of retinopathy of prematurity: Oxygen, gestational age, birth weight]. Medikal Network Oftalmoloji. 2000;7: 263-7.
- Oner A, Ozkiris A, Gunes T, Karakucuk S, Erkilic K, Cetin N. [Retinopathy of prematurity: two years screnning results]. Erciyes Tip Dergisi. 2005;27(3):104-9.
- Fielder AR, Posner EJ. Neonatal ophthalmology. In: Rennie JM, ed. Roberton's Textbook of Neonatology. 4th ed. London: Elsevier Churchill Livingstone; 2005. p.835-50.
- Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS. 2006;10(5):445-8. [Crossref] [PubMed]
- York JR, Landers S, Kirby RS, Arbogast PG, Penn JS. Arterial oxygen fluctuation and retinopathy of prematurity in very-low-birth-weight infants. J Perinatol. 2004;24(2):82-7. [Crossref] [PubMed]
- McColm JR, Geisen P, Hartnett ME. VEGF isoforms and their expression after a single episode of hypoxia or repeated oxygen fluctuations between hyperoxia and hypoxia: relevance to clinical ROP. Mol Vis. 2004;10: 512-20.
- The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for pretheshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105(2):295-310. [Crossref] [PubMed]
- Purohit DM, Ellison RC, Zierler S, Miettinen OS, Nadas AS. Risk factors for retrolental fibroplasia: experience with 3,025 premature infants. National collaborative study on patent ductus arteriosus in premature infants. Pediatrics. 1985;76:339-44.
- Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005;115(5):e518-25. [Crossref] [PubMed]
- Lad EM, Nguyen TC, Morton JM, Moshfeghi DM. Retinopathy of prematurity in the United States. Br J Ophthalmol. 2008;92(3):320-5. [Crossref] [PubMed]
- Ekinci A, Akcakaya AA, Yaylali SA, Sadigov F. [Retinopathy of prematurity: our results of four years' screen]. Okmeydani Tip Dergisi. 2015;31(2):75-81. [Crossref]
- Amer M, Jafri WH, Nizami AM, Shomrani AI, Al-Dabaan AA, Rashid K. Retinopathy of prematurity: are we missing any infant with retinopathy of prematurity? Br J Ophthalmol. 2012;96(8):1052-5. [Crossref] [PubMed]
- Muether PS, Kribs A, Hahn M, Schumacher J, Eifinger F, Kirchhof B, et al. No advanced retinopathy of prematurity stages 4 or 5 in a large high-risk German cohort. Br J Ophthalmol. 2012;96(3):400-4. [Crossref] [PubMed]
.: İşlem Listesi